Form: SC 13G/A

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

February 14, 1994

SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Published on February 14, 1994



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No. 5


MEDIQ Incorporated
______________________________________________________________________________
(Name of Issuer)

Common Stock
______________________________________________________________________________
(Title of Class of Securities)

584906101
______________________________________________________________________________
(CUSIP Number)

Check the following box if a fee is being paid with this statement
CUSIP No.

1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of above
persons
PNC Bank Corp. 25-143-5979


2) Check the Appropriate Box if a Member of a Group (See Instructions)
a)
b)

3) SEC USE ONLY


4) Citizenship or Place of Organization Pennsylvania


Number of Shares 5) Sole Voting Power 3,500
Beneficially Owned
By Each Reporting
Person With 6) Shared Voting Power 7,435,190


7) Sole Dispositive Power 0


8) Shared Dispositive Power 7,383,976


9) Aggregate Amount Beneficially Owned by Each Reporting Person
7,438,690*


10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)


11) Percent of Class Represented by Amount in Row (9) 31.20


12) Type of Reporting Person (See Instructions) HC






SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No. 5


MEDIQ Incorporated
______________________________________________________________________________
(Name of Issuer)

Common Stock
______________________________________________________________________________
(Title of Class of Securities)

584906101
______________________________________________________________________________
(CUSIP Number)

Check the following box if a fee is being paid with this statement
CUSIP No.

1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of
above persons
PNC Bank, National Association


2) Check the Appropriate Box if a Member of a Group (See Instructions)
a)
b)

3) SEC USE ONLY


4) Citizenship or Place of Organization United States of America


Number of Shares 5) Sole Voting Power 3,500
Beneficially Owned
By Each Reporting
Person With 6) Shared Voting Power 7,435,190


7) Sole Dispositive Power 0


8) Shared Dispositive Power 7,383,976


9) Aggregate Amount Beneficially Owned by Each Reporting Person
7,438,690


10) Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)


11) Percent of Class Represented by Amount in Row (9) 31.20

12) Type of Reporting Person (See Instructions) BK







Item 4 - Ownership:
(a) Amount Beneficially Owned:
7,438,690*


(b) Percent of Class:



(c) Number of shares to which such person has:
(i) sole power to vote or to direct the vote 3,500
(ii) shared power to vote or to direct the vote 7,435,190
(iii) sole power to dispose or to direct the disposition of 0
(iv) shared power to dispose or to direct the disposition of 7,383,976




Item 6 - Ownership of More Than Five Percent on Behalf of Another Person

See Schedule A attached.


* Beneficial ownership consists of 3,739,945 shares of Preferred, Series A
stock (CUSIP #584906200), which is not registered under the Securities
Exchange Act of 1934. This Preferred stock is convertible at any time to
common stock at a conversion rate of one to one, and thus is deemed to be
beneficial ownership of common stock. These shares are reportable under
Rule 13d-3d(i).

Schedule A


MEDIQ Incorporated


Item 6 - Ownership of More than five Percent on Behalf of Another
Person


This security is held in various trusts. The following persons may
have the power to direct the proceeds of sale and/or dividends in
their capacity as Co-Fiduciaries:

Lionel Felzer
17124 Newport Club Drive
Boca Raton, Florida 33496

Lionel Felzer is a Co-Fiduciary with PNC Bank, NA. for accounts
holding 3,626,997 shares of MEDIQ Inc. Common stock and 3,671,947
shares of MEDIQ Inc. Preferred, Series A stock.

Judith Shipon
1115 Devon Road
Rydal, PA 19046

Judith Shipon is a Co-Fiduciary with PNC Bank, NA. for accounts
holding 3,612,147 shares of MEDIO Inc. Common stock and 3,652,147
shares of MEDIQ Inc. Preferred, Series A stock.

Bessie Rotko
100 Bryer Estate #4-N
Elkins Park, PA 19117

Bessie Rotko is a Co-Fiduciary with PNC Bank, NA. for accounts holding
3,607,197 shares of MEDIQ Inc. Common stock and 3,647,197 shares of
MEDIQ Inc. Preferred, Series A stock.

Michael Rotko, Esquire
c/o Drinker, Biddle & Reath
Suite 1100
1345 Chestnut St.
Phila., PA 19107

Michael Rotko is a Co-Fiduciary with PNC Bank, NA. for accounts
holding 3,659,613 shares of MEDIQ Inc. Common stock and 3,704,563
shares of MEDIQ Inc. Preferred, Series A stock.





File: J\13G.93

John Iskrandt, Esquire
c/o Schnader, Harrison, Segal & Lewis
Suite 3600, 1600 Market St.
Phila., PA 19103

John Iskrandt is a Co-Fiduciary with PNC Bank, N.A. for accounts
holding 36,228 shares of MEDIQ Inc Common stock and 76,228 shares of
MEDIQ Inc. Preferred, Series A stock.

Thomas C. Rotko
P.O. Box 369
Unionville, PA 19375


Thomas C. Rotko is a Co-Fiduciary with PNC Bank, NA. for accounts
holding 21,258 shares of MEDIQ Inc. Common stock and 21,258 of MEDIQ
Inc. Preferred, Series A stock.

William L. Rotko
P.O. Box 369
Unionville, PA 19375


William L. Rotko is a Co-Fiduciary with PNC Bank, NA. for accounts
holding 21,258 shares of MEDIQ Inc. Common stock and 21,258 shares of
MEDIQ Inc. Preferred, Series A stock.





File: J\13G.93







Item 10 - Certification.

By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer
of such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.



Signature.

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.



February 14, 1994
_____________________________________________________________________
Date


_____________________________________________________________________
Signature


/s/ Howard I. Verbofksy, Managing Counsel
_____________________________________________________________________
Name/Title





_____________________________________________________________________
Date



_____________________________________________________________________
Signature


_____________________________________________________________________
Name/Title








Item 10 - Certification.

By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not
have the effect of changing or influencing the control of the issuer
of such securities and were not acquired in connection with or as a
participant in any transaction having such purposes or effect.



Signature.

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.



February 14, 1994
_____________________________________________________________________
Date


_____________________________________________________________________
Signature


/s/ Michelle A. O'Donnell, Assistant Vice President and
Assistant Regulatory Counsel
_____________________________________________________________________
Name/Title





_____________________________________________________________________
Date



_____________________________________________________________________
Signature



_____________________________________________________________________
Name/Title